Prophylactic cancer vaccines engineered to elicit specific adaptive immune response

DW Crews, JA Dombroski, MR King - Frontiers in Oncology, 2021 - frontiersin.org
Vaccines have been used to prevent and eradicate different diseases for over 200 years,
and new vaccine technologies have the potential to prevent many common illnesses …

Infection of human papillomaviruses in cancers of different human organ sites

S Shukla, AC Bharti, S Mahata, S Hussain… - Indian Journal of …, 2009 - journals.lww.com
Clinico-epidemiological and molecular studies have established the casual link between
Human Papillomavirus (HPV) infection and cervical cancer as also association of HPV …

Human papillomavirus and risk factors for cervical cancer in Chennai, India: A case‐control study

S Franceschi, T Rajkumar, S Vaccarella… - … journal of cancer, 2003 - Wiley Online Library
To evaluate the role of human papillomavirus (HPV) and other risk factors in the aetiology of
invasive cervical carcinoma (ICC), we conducted a hospital‐based case‐control study in …

TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies

SJ Klug, M Ressing, J Koenig, MC Abba… - The lancet …, 2009 - thelancet.com
Background Cervical cancer is caused primarily by human papillomaviruses (HPV). The
polymorphism rs1042522 at codon 72 of the TP53 tumour-suppressor gene has been …

Prospects and prejudices of human papillomavirus vaccines in India

BC Das, S Hussain, V Nasare, M Bharadwaj - Vaccine, 2008 - Elsevier
Cervical cancer is the most common cancer and a leading cause of cancer deaths among
women in develo** countries. The disease is caused due to persistent infection of one or …

p53 codon 72 polymorphism and cervical neoplasia: a meta-analysis review

A Koushik, RW Platt, EL Franco - Cancer Epidemiology Biomarkers …, 2004 - aacrjournals.org
Abstract The Arg/Arg genotype versus Arg/Pro or Pro/Pro at codon 72 of the p53 gene has
been implicated as a risk marker in cervical neoplasia. However, research on this topic has …

A meta-analysis of human papillomavirus type-distribution in women from South Asia: implications for vaccination

N Bhatla, N Lal, YP Bao, T Ng, YL Qiao - Vaccine, 2008 - Elsevier
OBJECTIVE: To determine human papillomavirus (HPV) prevalence and type-distribution in
women from South Asia, with and without cervical lesions, in order to estimate the impact of …

Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal

R Sankaranarayanan, N Bhatla, PE Gravitt, P Basu… - Vaccine, 2008 - Elsevier
Although one-third of the world cervical cancer burden is endured in India, Bangladesh,
Nepal and Sri Lanka, there are important gaps in our knowledge of the distribution and …

Blood‐based biomarkers of human papillomavirus–associated cancers: A systematic review and meta‐analysis

S Balachandra, SB Kusin, R Lee, JM Blackwell… - Cancer, 2021 - Wiley Online Library
Background Despite the significant societal burden of human papillomavirus (HPV)–
associated cancers, clinical screening interventions for HPV‐associated noncervical …

Papillomavirus and disease in humans and animals

MS Campo - Veterinary and Comparative Oncology, 2003 - Wiley Online Library
Papillomavirus (PV) induces exophytic lesions (papillomas, warts) and flat lesions (flat warts,
cervical intraepithelial neoplasia) in cutaneous and mucosal epithelia. The lesions are …